Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 6;13(11):3280–3296. doi: 10.7150/jca.74829

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

Network graphs of different outcomes: A, CD3⁺; B, CD4⁺; C, CD8⁺; D, CD4⁺/CD8⁺; E, VEGF; F, AFP; G, Clinical effectiveness rate; H, Quality of Life. Note: The yellow line: Sorafenib; The black line: systematic chemotherapy; VEGF: vascular endothelial growth factor; AFP: alpha fetoprotein; KLTI: Kanglaite injection; ADI: Aidi injection; FFBMJN: Fufang Banmao Jiaonang; PXP: Pingxiao Pian; KAI:Kangai injection; CKSI: compound kushen injection; SQFZI: Shenqifuzheng injection; LKP: Longkui Pian; SMI: Shenmai injection; XZYGP: Xiaozheng Yigan Pian; XHJN: Xihuang Jiaonang; Huaier: Huaier granule; Sor: sorafenib; ST: systemic therapy.